Professional Documents
Culture Documents
Roy Smith
Oxygen
Uses
Increase supply of oxygen HYPOXIC EVENT Airway / BVM NR Simple mask Cannula
Dose
Nitroglycerine
Uses
Vasodilatation AMI, CP, CHF Metered dose 0.4 mg SL 5 mcg/min increase every 5-10 min until desired clinical response Viagra within 24 hrs Rt Ventricular Infarctions
Dose
Relative contraindications
Morphine
Uses
Decreases myocardial oxygen consumption AMI,CHF
Dose
2-10 mg IVP
Naloxone
Mechanism of action
Competitive opioid antagonist
Uses
Opioid antagonism MS OD
Dose
0.4 2.0 mg
Aspirin
Uses
Stops platelet aggregation, Asprin blocks secretion of thromboxane A2 from the platelets, there by inhibiting platelet agregation.
Dose
162 - 325 mg oral
Adenosine
Mechanism of action
Found naturally in all body cells Slows sinus rate, slows conduction through the AV Node.
Uses
SVT, PERSISTENT PSVT
Dose
6,12,12 mg RIVP
Amiodarone
Mechanism of action
BLOCKS- sodium, potassium, sympathetic, and calcium channels
Uses
VT VF WCT
Dose
300 mg VT with pulse 150 mg x 2
Atropine
Mechanism of action
Parasympatholytic
Uses
bradycardias
Dose
0.5 1.0 mg 0.04 mg/kg max dose
Dose
Dose
0.25 g/kg
Digoxin
Mechanism of action
Suppresses SA node, prolongs AV conduction, positive inotrope, incr peripheral resistance via inhibition of Na/K-ATPase making more Ca available to actin & myosin Reduces conduction through the AV node. 0.4-0.6 mg IV x1
Uses
Dose
Epinepherine
Mechanism of action
Stimulates both alpha and beta receptors, increases chronotropic, iontropic effects. Increased contraction, rate, and vascular resistance.
Uses
Dose
1 mg IVP 3-5 min
Lidocaine
Mechanism of action Uses
Blocks sodium channels, decreasing myocardial contraction Raises VF threshold antiarrythmic 1-1.5 mg/kg IVP 3 mg/kg max
Dose
Magnesium Sulfate
Mechanism of action
Smooth muscle relaxant, reduces calcium action in action potential.
Uses
Torsades
Dose
1-2 G over 1-2 minutes
Procainamide
Mechanism of action
Decreases conduction velocity in the atria, ventricles, and His- Purkinje system, significant portion metabolized by acetylprocainamide having significant antiarrythmic activity.
Uses
Stable SVT, A-Fib, A-Flutter, WPW, WCT, VT,VF
Dose
20-30 mg/min
Dopamine
Mechanism of action
Immediate precursor of norepinephrine in the body.
Uses
Cardiogenic shock
Dose
2-20 mcg/kg/min
Norepinepherine
Mechanism of action
Perpherial vasoconstrictor, coronary artery dilator.
Uses
Cardiogenic shock
Dose
8-12 mcg/min
Dobutamine
Mechanism of action
Stimulate alpha1, beta 1, and beta2, positive inotrope.
Uses
Cardiogenic shock due to chf, pulmonary congestion.
Dose
2-20 mcg/kg/min
Vasopressin
Mechanism of action
Antidiuretic hormone Binds to specific receptors vasporessin receptors, V1(V1a, V1b),V2 Vasopressin exerts a greater vasoconstrictive effect than api, causes a greater artery tonevasopressin does not increase myocardium oxygen consumption, or excessive lactate production.
Uses
Alternative to EPI in VT/VF
Dose
40 units 1 time.
Calcium chloride
Mechanism of action
Provides more calcium ion for an increase in contractile force.
Uses
Hyperkalemia, hypocalcemia, calcium channel blocker toxicity, magnesium toxicity, betablocker toxicity
Other medications
Sodium bicarbonate Furosemide
Sodium Bicarbonate
Mechanism of action
Increases plasma bicarbonate, buffers hydrogen.
Uses
Hyperkalemia, acidosis, tricyclic, antidepressant OD, hypercarbic lactic acidosis.
Dose
1 meq/kg
Furosemide
Mechanism of action
Inhibits reabsorption of sodium in the loop of henly,
Uses
Loop diuretic
Dose
1 mg/kg 80 max